Pictet Asset Management (Switzerland)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$106M Buy
2023
Q1
$64M Buy
2022
Q4
$52.9M Buy
2022
Q3
$39.3M Sell
2022
Q2
$63.6M Sell
2022
Q1
$90.9M Buy
2021
Q4
$76.1M Buy